6NAX

Olfactomedin domain of mouse myocilin

6NAX の概要

• エントリーDOI: 10.2210/pdb6nax/pdb
• 分子名称: Myocilin, CALCIUM ION, SODIUM ION, ... (6 entities in total)
• 機能のキーワード: murine, olfactomedin, protein binding
• 由来する生物種: Mus musculus (Mouse)
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 62987.70

構造登録者

Patterson-Orazem, A.C.,Hill, S.E.,Lieberman, R.L. (登録日: 2018-12-06, 公開日: 2019-03-13, 最終更新日: 2024-10-16)

主引用文献

Patterson-Orazem, A.C.,Hill, S.E.,Wang, Y.,Dominic, I.M.,Hall, C.K.,Lieberman, R.L.
Differential Misfolding Properties of Glaucoma-Associated Olfactomedin Domains from Humans and Mice.
Biochemistry, 58:1718-1727, 2019

PubMed Abstract: Mutations in myocilin, predominantly within its olfactomedin (OLF) domain, are causative for the heritable form of open angle glaucoma in humans. Surprisingly, mice expressing Tyr423His mutant myocilin, corresponding to a severe glaucoma-causing mutation (Tyr437His) in human subjects, exhibit a weak, if any, glaucoma phenotype. To address possible protein-level discrepancies between mouse and human OLFs, which might lead to this outcome, biophysical properties of mouse OLF were characterized for comparison with those of human OLF. The 1.55 Å resolution crystal structure of mouse OLF reveals an asymmetric 5-bladed β-propeller that is nearly indistinguishable from previous structures of human OLF. Wild-type and selected mutant mouse OLFs mirror thermal stabilities of their human OLF counterparts, including characteristic stabilization in the presence of calcium. Mouse OLF forms thioflavin T-positive aggregates with a similar end-point morphology as human OLF, but amyloid aggregation kinetic rates of mouse OLF are faster than human OLF. Simulations and experiments support the interpretation that kinetics of mouse OLF are faster because of a decreased charge repulsion arising from more neutral surface electrostatics. Taken together, phenotypic differences observed in mouse and human studies of mutant myocilin could be a function of aggregation kinetics rates, which would alter the lifetime of putatively toxic protofibrillar intermediates.

PubMed: 30802039
DOI: 10.1021/acs.biochem.8b01309

実験手法

X-RAY DIFFRACTION (1.551 Å)